2.5mg Oncolet Tablets
Get Price Quote
10 Box (MOQ)
Letrozole Tablets
Get Price Quote
Letrozole tablets USP 2.5 mg is used in the treatment of advanced breast cancer in women. Letrozole is the second in a new class of third-generation selective oral aromatase inhibitors. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen. The recommended dose of Letrozole is 2.5 mg once daily, at the same time each day, taken with or without food.
Best Deals from Letrozole Tablets
Fempro Letrozole 2.5mg Tablet
85 Per Strip
10 Box (MOQ)
Letrozole tablet IP Letgem Tablets
2,800 - 2,880 Per BOXES
100 Pack (MOQ)
Letrozole Tablets
Get Price Quote
100 Box (MOQ)
LETROZOLE USP
Get Price Quote
Letrodac 2.5mg Tablets
Get Price Quote
Letroz Tablets
200 Per Strip
1 Box (MOQ)
Letmgo Tablets
Get Price Quote
FEMPRO 2.5mg Tablets
Get Price Quote
10 Box (MOQ)
0.0
Website
Letrozole 2.5mg Tablets
Get Price Quote
500 Box (MOQ)
Fempro Tablets
Get Price Quote
Letrozole Tablets
Get Price Quote
Letrozole Tablets
67 Per Strip
500 Box (MOQ)
Letronat
200 - 230 Per Strip
1000 Strip (MOQ)
Letronat pill is an aromatase inhibitor. It is normally prescribed to treat breast cancer in ladies who no longer have durations, both due to menopause or after surgical treatment or chemotherapy. It's also used to deal with infertility induced because of anovulation (all through menstrual cycle egg cell from ovaries isn't always released).
Letrozole Tablets
Get Price Quote
Demega formulations India is a major exporter ofLETROZ (generic) used to treat early breast cancer in women who have experienced menopause and who have already been treated with tamoxifen since 5 years since LETROZ (generic) works by decreasing the amount of estrogen and slows or stops the growth of some types of breast cancer cells which need estrogen to grow. Letrozole is known by brand name "" in USA
Letrozole Tablets 2.5mg
400 - 450 Per box
100 Box (MOQ)
0.0
Website
Ribociclib and Letrozole Tablets
Get Price Quote
FDA expands ribociclib indication in HR-positive, HER2-negative advanced or metastatic breast cancer. On July 18, 2018, the Food and Drug Administration expanded the indication for ribociclib (Kisqali, Novartis Pharmaceuticals Corporation) in combination with an aromatase inhibitor for pre/perimenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer, as initial endocrine-based therapy. The Kisqali Femara Co-Pack is a prescription that contains two medications, ribociclib (Kisqali) and letrozole (Femara), used as a first-line treatment for adults who have advanced or metastatic hormone-receptor-positive human epidermal growth factor-2 receptors (HER2)-negative breast cancer.1 Metastatic cancer is cancer that has spread from the primary site to other areas of the body. Generic Name: Ribociclib and letrozole Brand Name(s): Kisqali Femara Co-Pack Drug Availability: Prescription Administration Route: Oral Therapeutic Classification: CDK4/6 inhibitor and aromatase inhibitor Available Generically: No Active Ingredient: Ribociclib and letrozole Dosage Form(s): Tablet
LETROZOLE TABLETS USP 2.5 MG
Get Price Quote
LETROZOLE TABLETS USP 2.5 MG oral non-steroidal Aromatase inhibitor Letrozole Tablets USP 2.5 mg is an oral non-steroidal Aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. 3s corporation is Supplier,Exporter ,Wholesaler for Letrozole Tablets USP 2.5 mg in India. We even offer contract manufacturing services from WHO GMP approved factories. ADDITIONAL INFORMATION Letrozole is contraindicated in women having a pre-menopausal hormonal status, during pregnancy and lactation. SIDE EFFECTS The most common side effects are sweating, hot flashes,arthralgia (joint pain), and fatigue. Generally, side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is in certain patient populations such as post-menopausal women or osteoporotics.
Letrozole Tablets
148 Per Strip
50 Strip (MOQ)
Post Free Ad
